First Time Loading...

Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 7.12 AUD -0.28% Market Closed
Updated: May 10, 2024

Mayne Pharma Group Ltd
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayne Pharma Group Ltd
Tax Provision Peer Comparison

Comparables:
RCE
NEU
BOT
PBP
C
CU6

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Mayne Pharma Group Ltd
ASX:MYX
Tax Provision
-AU$47.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Tax Provision
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Tax Provision
-AU$48.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Tax Provision
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Tax Provision
-AU$4.3m
CAGR 3-Years
-17%
CAGR 5-Years
-23%
CAGR 10-Years
-56%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Tax Provision
-AU$103.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mayne Pharma Group Ltd's Tax Provision?
Tax Provision
-47.7m AUD

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Tax Provision amounts to -47.7m AUD.

What is Mayne Pharma Group Ltd's Tax Provision growth rate?
Tax Provision CAGR 1Y
36%

Over the last year, the Tax Provision growth was 36%.